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Glucocorticoids (GCs) are the final effector products of a neuroendocrine HPA/HPI axis
governing energy balance and stress response in vertebrates. From a physiological
point of view, basal GC levels are essential for intermediary metabolism and participate
in the development and homeostasis of a wide range of body tissues, including the
skeleton. Numerous mammalian studies have demonstrated that GC hormones exert a
positive role during bone modeling and remodeling as they promote osteoblastogenesis
to maintain the bone architecture. Although the pharmacological effect of the so-called
stress hormones has been widely reported, the role of endogenous GCs on bone mineral
metabolism as result of the endocrine stress response has been largely overlooked
across vertebrates. In addition, stress responses are variable depending on the stressor
(e.g., starvation, predation, and environmental change), life cycle events (e.g., migration
and aging), and differ among vertebrate lineages, which react differently according to
their biological, social and cognitive complexity (e.g., mineral demands, physical, and
psychological stress). This review intends to summarize the endogenous GCs action
on bone metabolism of mammals and fish under a variety of challenging circumstances.
Particular emphasis will be given to the regulatory loop between GCs and the parathyroid
hormone (PTH) family peptides, and other key regulators of mineral homeostasis and
bone remodeling in vertebrates.
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INTRODUCTION
Glucocorticoids (GCs) are central steroid hormones on endocrine stress response modulation
and whole-body homeostasis in vertebrates. Downstream of the hypothalamic-pituitary-
adrenal/interrenal (HPA/HPI) axis, regulated by a negative feedback loop, circulating CGs exert
diverse actions by binding to glucocorticoid receptor (GR) placed on nearly every tissue in the body
(1). In addition to well-known effects on glucose metabolism, immune system, reproduction,
feeding, circadian rhythm, behavior, and cognition, GCs also regulate bonemetabolism (2–4). Bone
is ametabolically active tissue, shaped at an early stage of development and continuously remodeled
throughout an animals’ lifetime. Bone remodeling regulated by systemic hormones, neural, and
local factors, involves the coupled action of osteoclasts, osteoblasts, and osteocytes to replace old
and damaged bone. This process preserves the mechanical strength and stiffness of the skeleton,
maintains calcium-phosphorus homeostasis, acid/base balance, and releases growth factors as well
as organic material embedded in bone (5, 6).
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In vertebrates, the GCs action is complex. Despite stress
hormones have long been considered as catabolic hormones,
a dual metabolic effect has been found in the skeleton.
Physiological levels of GCs are vital for normal skeletogenesis
and bone mass accrual, which highlights an important anabolic
role (7). However, an increase of GCs over the basal levels causes
reduced bone growth, bone resorption and bone mineral loss
as seen in Cushing’s syndrome and GCs-induced osteoporosis
(GIO), as well as other associated pathologies such as diabetes or
sarcopenia (8–10). In humans, Cushing’s syndrome (also named
hypercortisolism) is characterized by an increased production of
endogenous cortisol or GCs drugs resulting in detrimental effects
on bone metabolism (11). Patients suffering from Cushing’s
disease exhibit a reduced bone mineral density, increased risk of
fracture, suppression of osteoblastic differentiation and apoptosis
of both osteoblasts and osteoclasts, among other symptoms (12,
13). Moreover, sustained exposure to exogenous GCs is also
responsible for the so-called GIO as a consequence of long-term
GC therapy (14). GIO has recently been investigated in fish, with
zebrafish incubated in GCs showing reduced bone growth and
impaired bone regeneration (15).
On the other hand, endogenous/exogenous GCs have been
proposed to act as key regulators of osteocalcin expression in
bone. Osteocalcin is a calcium-binding peptide synthesized by
osteoblasts and osteocytes, involved in skeletal mineralization
and, regulation of insulin production (16). Elevated GC levels
suppress the osteoblast activity and inhibit the osteocalcin release
in mammals (17). Therefore, GCs affecting bone formation also
indirectly cause changes in whole-body energy metabolism (8).
GCs are known to interact with parathyroid hormone (PTH)
family members. Human PTH1 (PTH—the master regulator
of bone mineral homeostasis) showed corticotropic activity
in adrenocortical cell cultures (18). A feedback regulatory
loop between cortisol and PTH3 (parathyroid hormone like
hormone—PTHLH) has been described in vertebrates (18–
20). In mammals, PTH3 participates in embryonic skeletal
development (21), calcium mobilization during fetal-placental
transport (22) and lactation (23, 24). While in fish, duplicated
Pth3 factors are hormones involved in calcium uptake (25,
26), mineral release from scales (27), skeletogenesis and early
mineralization (28).
To date, a substantial body of research has focused on the
bone effects caused by a pathological increase of endogenous
and exogenous GC levels, but few studies have reported the
changes produced on bone metabolism due to the elevation
of stress-induced GCs. As a natural mechanism, all organisms
react to extrinsic and intrinsic stressors through the GC-
mediated hormonal response to restore the equilibrium and
preserve homeostasis. In this context, the skeleton is one of
the target organs of the stress hormones and bone remodeling
is an essential process that enables it to respond to changing
conditions by modifying its structure and mineral composition.
Stress responses are characterized by being variable across
vertebrates and they are closely related to the type of stressor
as well as the lineage-specific biology and ecology (29, 30).
In this article, we review the action of stress-induce GCs on
bone metabolism in vertebrates. Briefly, we define the current
knowledge on the effect of endogenous GCs on bone under
normal physiological conditions. Then, we describe how several
stress factors affect bone mineral metabolism in two different
vertebrate lineages: mammals (primarily human), which are
endothermic terrestrial vertebrates, and fish, characterized as
ectothermic aquatic vertebrates.
ENDOGENOUS GCs ON BONE
DEVELOPMENT AND HOMEOSTASIS
Endogenous GC hormones regulate the expression of target
genes through GR signaling within bone cells, affecting skeletal
development and metabolism. The skeleton responsiveness to
GCs and the subsequent activation or inhibition of the gene
expression depends on the level of circulating stress hormones,
the intracellular availability of active GCs and the GR activity
(1). To date the study of GC actions on bone has focused on
mammalian models. Initially, investigations were based on the
global GR deletion which led to premature death in newborn
mice by respiratory failure (31). This was followed by more
advanced molecular approaches such as the bone cell-specific GR
gene deletion or the osteoblasts-targeted transgenic expression
of 11βHSD2 (enzyme that catalyzes the conversion of active
to inactive GCs) to disrupt intracellular GC signaling. These
studies contributed to better define the endogenous GCs effects
under various physiological conditions. In vivo and in vitro
studies carried out in cell cultures derived from 11βHSD2
overexpressing transgenic mice have reported the positive action
of endogenous GCs during bone development (32, 33). GCs
appeared to be essential for mice osteoblastogenesis as they
control the lineage commitment of mesenchymal progenitor
cells through osteoblasts by promoting the activation of Wnt
signaling. In turn, Wnt proteins act on mesenchymal cells to
increase the expression of β-catenin and RUNX2, the master
regulator of osteoblast differentiation. Also, osteoblast GC
activity disruption in 11βHSD2 transgenic mice revealed an
important role for normal intramembranous ossification and
proper cartilage removal during cranial development (34, 35). In
addition to the GC actions during skeletogenesis in mammals,
several studies have pointed out that endogenous GCs are
also required to maintain the bone mass accrual and skeletal
integrity across adulthood. Inactivation of osteoblast-specific GC
signaling by using a GR knockout mouse model (36) or 11βHSD2
expressing transgenic mice (37, 38) resulted in a decrease of bone
mineral density in adults, which was dependent on the skeletal
site and sexual maturity (37). Moreover, a downregulation in
the expression of osteoblasts differentiation markers (i.e., Col1a1,
Runx2, bone sialoprotein, and osteocalcin) was found, suggesting
failed osteoblastogenesis as well as mature osteoblast function
(36, 38). Therefore, the major effects of endogenous GCs on
bone development and homeostasis are probably due to its
direct actions on osteoblasts. Nevertheless, due to a close and
reciprocal interconnectivity between osteoblasts and osteoclasts
for skeletal metabolism, in vivo studies involving endogenous
GCs and osteoclasts are needed to specifically dissect the cellular
actions on the skeleton.
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STRESS-INDUCED GLUCOCORTICOID
EFFECTS ON BONE MINERAL
METABOLISM
GCs, including cortisol and/or corticosterone in mammals as
well as cortisol in fish, are synthesized in the adrenal cortex of
mammals, but in the interrenal tissue of the head kidneys in
teleosts (39). In response to stress, the pituitary gland signals
the adrenal gland/interrenal tissue to release GCs. These GCs
are released into the blood and initiate numerous cellular events
that promote changes in cells and tissues for adaptation to
stressful stimuli (40) (Figure 1). In this context, it is important
to distinguish between the degrees of stress that can ultimately
affect bone homeostasis. Acute stress is sudden and transitory
and it may trigger skeletal remodeling as an adaptive response,
which confers survival advantage (41). After exposure to an acute
stressor, GCs levels are rapidly increased in the blood before
returning to basal levels via negative feedback mechanisms.
However, chronic stress is a long-term stressor, sustained for a
prolonged period of time or due to a frequently occurring stressor
(41), through which GCs levels remain elevated which could
lead to several pathological conditions including bone mineral
loss (2). Stress-induced bone resorption can result in calcium
and phosphate release and it can lead to irreversible damage
of the bone architecture resulting in mechanical instability. In
addition to intensity and duration of the stressor, the stress
responses of vertebrates are highly variable depending on the type
of stressor and the way it is perceived by each kind of species.
Some key stress factors affecting bone mineral metabolism in
mammals and fish are described in this section including mineral
demands, environmental change, starvation, physical exercise,
psychological stress, and aging (Figure 1).
Mineral Demands
The skeleton is the major mineral storage organ in the vertebrate
body and takes part in the regulation of calcium-phosphate
metabolism. Thus, skeleton provides calcium and phosphate
through bone resorption to compensate the inadequate
availability of minerals in the environment and/or in the diet to
maintain essential ionic levels in blood (5, 42). Unlike terrestrial
vertebrates, fish can absorb minerals from surrounding water
across the skin, oral and branchial epithelium, so stressors
related to water and ion homeostasis have a greater physiological
impact (29). In teleosts, the role of cortisol on osmoregulation
has widely been reported (43) but, the contribution of cortisol
on the ionic balance related to bone mineral homeostasis has
received less attention (44). Previous studies showed that fish
exposed to low calcium water levels give rise to high plasma
cortisol levels in rainbow trout (45, 46), and stimulates the
gene expression of steroid 11β-hydroxylase (final-step enzyme
for cortisol synthesis) as well as glucocorticoid receptor (gr)
in zebrafish (47). Moreover, cortisol treatment was shown
to induce in vitro calcium transport in cultured rainbow
trout gill epithelium, which supports its hypercalcemic role
(48). Also, tilapia exposed to exogenous cortisol showed an
increase in calcium uptake and upregulation of epithelial Ca2+
FIGURE 1 | Stress-induced cortisol affecting bone mineral metabolism in
human and fish. Stressors including mineral demands, environmental change,
starvation, physical exercise, psychological stress, or aging trigger the
hypothalamic-pituitary-adrenal/interrenal (HPA/HPI) axis activation in human
and fish, respectively, leading acute and chronic effects on the skeleton.
channel (ecac) gene expression (49). It would therefore appear
that teleost fish regulate the calcium uptake to cope with a
fluctuating water environment which is closely related to bone
homeostasis. Alternatively, studies with juvenile seabream
showed a plasma cortisol increase after prolonged exposure
to low calcium availability in the water and/or diet, which
resulted in reduced whole-body calcium and phosphorus
contents (50). In the European eel, chronic cortisol treatment
induced mineral loss in vertebral bone through osteoclastic
resorption and osteocytic osteolysis (51). Interestingly, it has
been suggested that cortisol mobilization of bone mineral
stores in eel may be evidence of an ancestral stress-induced
physiological process (51) related to the effects of stress events in
mammals (e.g., starvation, physical exercise, psychological stress,
or aging).
An interaction between hypercalcemic PTH factors regulating
bone mineral metabolism and cortisol has been reported in
mammals and fish (Table 1). Both PTH1 and PTH3, stimulated
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TABLE 1 | Summary of some of the reported studies including PTH-cortisol regulatory interactions in mammals and fish.
Hormone Species Action Tissue References
PTH1 Homo sapiens Cortisol release Adrenocortical cells culture 18
PTH3 Homo sapiens Cortisol release Adrenocortical cells culture 18
Cortisol Mus musculus PTH3 expression increase Kidney 19
Pth3 Sparus aurata Cortisol release Isolated interrenal glands 20
Cortisol Sparus aurata Pth3 expression decrease Blood 52
cortisol release from human adrenocortical cells in vitro
(18), although only the gene encoding PTH3 appears to be
regulated by GCs (19). Similarly, piscine Pth3 showed in vitro
corticotropic activity on isolated sea bream interrenal glands
(20). In turn, sustained cortisol levels in sea bream as a
consequence of a 24h confinement stressor or in vivo cortisol
intraperitoneal injection resulted in a decrease in plasma Pth3
levels (52). Similar to cortisol, sea bream PTH3 is produced
in interrenal tissue in fish (20, 53) and therefore an autocrine
and/or paracrine regulatory mechanism between these two
hormones was proposed (52). However the underlying molecular
regulation remains unclear and it is possible that Pth3 acts
indirectly at other levels of the HPI axis. Contradictory results
regarding the cortisol-Pth3 reciprocal regulation were found
in sea bream exposed to limited calcium availability in the
long-term. Fish either under low calcium water along with
a calcium-sufficient diet or under regular calcium water but
calcium-deficient diet showed elevated plasma cortisol and Pth3
levels (50).
Environmental Change
Environmental stressors like temperature fluctuations are a
critical feature of homeostasis in an organism. This is of
particular relevance for ectothermic animals such as fish, where
temperature directly influences their normal physiology. Sea
bream exposed to water temperatures below 13◦C develop
winter syndrome, which is characterized by a multi-organ
dysfunction together with a high but transient rise of plasma
cortisol levels triggering a stress response (54, 55). A recent
study in sea bream has revealed the impact of cold challenge,
which increased the cortisol production and affected bone
homeostasis in juveniles (55). Thus, fish exposed to low
temperature during early development showed altered enzymatic
activities of alkaline phosphatase (ALP) and tartrate-resistant
acid phosphatase (TRAP) as well as calcium content changes
on the vertebral bone (55). Interestingly, temperature is also
a modulator of the expression of PTH family members.
Zebrafish embryos exposed to cold (18◦C) stress showed up-
regulated mRNA levels of pth1a, pth1b, pth3a, pth3b, and
pth1rb, while those exposed to a hot (38◦C) stress down-
regulated mRNA levels of these genes (56). Therefore, it is
likely that such changes may impact mineral balance, altering
bone development in embryos. However, to our knowledge,
there are no studies showing a correlation between temperature-
driven levels of cortisol and PTH family members affecting bone
metabolism.
Starvation
A common stressor in the wild is food deprivation, which can be
caused by adverse weather, decline in prey availability, increased
predator pressure and migration or hibernation, among others.
Under these conditions, it is well know that GCs are released
into the blood to promote the mobilization and utilization of
energy reserves and mineral stores in vertebrates (57). Regarding
migratory teleost fish like salmonids, spawning migration is a
very challenging situation since they undergo not only fasting
but also exhausting exercise, changes in osmoregulation and
sexual maturation (58). Thus, migratory salmonids, essentially
as adults returning to spawning grounds, experience a strong
activation of the neuroendocrine axis resulting in elevated
plasma corticosteroid levels (59) as well as marked resorption
of the skeleton. In particular, the anadromous Atlantic salmon
was reported to experience a dramatic skeletal transformation
caused by a decrease in the bone mineral content, halastic
demineralization, osteoclastic resorption, and reduced vertebral
bone mass (60–62). Nevertheless, a recent study in the migratory
European eel showed that sexually mature fish via cortisol
injection exhibited severe bone loss in the vertebrae and skull,
while plasma cortisol levels were reduced (63). Therefore,
a cortisol-independent bone resorption mechanism has been
suggested in migratory eels (63). Some mammalian species
also experience a situation of nutritional deprivation during
hibernation similar to that observed in migratory fish. Small
mammals such as little brown bats and hamsters lose a significant
bone mineral volume during hibernation (64, 65), but only high
plasma cortisol levels have been detected in bats (66). On the
other hand, cortisol is increased in hibernating bears, however
they maintain a typically balanced bone turnover which prevents
bone reabsorption excess and osteoporosis (67, 68). Furthermore,
fasting studies in humans have shown an increase in blood
cortisol concentration (69) accompanied by a decrease of PTH
secretion, which is suggested to have some positive effect on the
bone health (70).
Physical Exercise
Physical exercise represents a stressful experience for all
organisms. In mammals, physical activity promotes direct
effects on bone metabolism via mechanical forces (i.e., weight-
bearing activities), but also indirectly through hormonal factors
(71). Hence, exercise causes HPA axis activation and the
subsequent release of GCs into the blood. Although physical
exercise has been reported to prevent bone mineral loss and
to sustain bone health, long-term intense exercise is reported
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to cause hypercortisolism, which can result in osteopenia
and osteoporosis (71). Some studies have showed that over-
trained runners exhibit elevated ACTH and cortisol basal
concentrations compared with moderately trained runners and
sedentary subjects (72). However, the HPA axis activation was
attenuated in over-trained runners after exposure to an acute
exercise, suggesting a certain adaptation to physical exercise
(72). Other investigations have reported that highly trained
male master cyclists (73) and competitive male cyclists show
low bone mineral density in the hip and spine, however there
is no clear association between bone mineral content and
excess of GC secretion (74). Exercised fish show improved
growth and increased bone remodeling (75). However, the most
extreme examples of possible interactions between GCs and bone
metabolism during exercise may arise from migratory fish such
as the salmonids or eels (see also under Aging). In experiments
that were aimed to simulate to some extent the skeletal-loss
consequences of a 5,000 km migration to reproductive grounds
(51, 63) demonstrated that cortisol induced a significant bone
demineralization of Europen eel vertebrae, with significant
decreases of the mineral ratio and the degree of mineralization
of vertebral sections. Using histology and image analysis of
ultrathin microradiographs they showed the induction by
cortisol of different mechanisms of bone resorption, including
periosteocytic osteolysis and osteoclastic resorption. These effects
were further enhanced by sex steroids. Specificity of cortisol
action was investigated by comparison with the effects of sex
steroids, namely estradiol, related to the stimulated synthesis
of vitellogenin (Vg), an oviparous specific phospho-calcio-
lipoprotein. Such effects of estradiol have been profusely shown
in salmonids (76). However, in above study, the ready-to-migrate
eels were not actually exercised but simply injected with steroids
and thus the evidence for the effects of exercise-related GCs.
Psychological Stress
It has recently been demonstrated that psychological stress affects
bone metabolism in humans and some animal models (77–81).
Although the psychological stress response is complex, as it
depends on individual interpretation, it has been suggested that
long-term psychological stress produces altered HPA axis activity
and as a consequence, GC release affecting bone health (77). In
rats, chronic psychological stress by anxiety neurosis results in
the loss of mandibular bone matrix (78). Post-traumatic stress
disorder, which is related to altered serumGCs, caused a decrease
of bone mineral density and bone mineral contents in young
mice (79). In humans, the relationship between depression and
bonemineral density has also been associated with stress-induced
cortisol effects. Post-menopausal womenwith depression showed
loss of bone mineral density in the lumbar spine and femur
compared to non-depressed subjects, as well as a higher cortisol
production after an acute stress experience (80). Furthermore,
pre-menopausal women suffering from chronic depression
presented a negative correlation between cortisol levels and bone
mineral density, as well as low osteocalcin levels suggesting
a decrease in bone formation (81). Recently there has been
increased attention to the impact of social or psychological stress
in fish, in parallel with the recognition of an increased degree of
sentience and multiple individual coping styles, to which some
may even refer as “personalities” in fish. The way fish exhibiting
those different coping styles address stressful events determines
to some extent their rank, access to food, energy expenditure,
growth rates and cortisol response levels (82, 83). However, to
date, there is no information on the impact of psychological stress
and induced GC levels on fish bone.
Aging
Aging is an imbalance between damage and repair that makes
organisms undergo an increasing vulnerability to challenges
during the post-maturational life, decreasing their ability to
survive (84). Along these lines, aging disturbs the homeostatic
system but perhaps it should not be considered as a stressor
since it does not elicit per se a physiological stress response.
However, aging is closely related to responsivity to stress and it
seems to produce similar effects to those seen in the chronic stress
response. In mammals, aging causes greater HPA axis activation
and thereby an excess production of GCs that negatively affect
bone metabolism (7). It has been proposed that HPA axis
hyperactivity could be due to a decrease in the number of GC
receptors in the brain, which in turn affects the negative feedback
regulation, but can also be the result of repeated stress events (7).
An age-related increase of corticosterone as well as upregulation
of 11βHSD1 (enzyme that activates GCs) expression in bone,
which led to reduced bone vasculature and skeletal fragility
in mice (85). Studies in humans have provided evidence that
elevated cortisol levels affect bone mineral density. Thus, elderly
men and women with a high level of evening salivary cortisol
had a reduced bone mineral density in the lumbar spine (86).
Also, high plasma cortisol levels in older women contributed
to bone loss in the femoral neck (87). Additionally, a positive
correlation between cortisol concentration and bone loss rate
was found in the lumbar spine in elderly men (88). Fish grow
continuously throughout their lives and usually their skeleton
maintains its integrity with aging. A few exceptions can be
found in semelparous species, such as many salmonids and
eels (51, 63, 76) in which sexual maturation, reproduction and
related skeletal remodeling coincide with the end of life. Both
GC and sex steroids increase along the migratory route and peak
levels coincide with important organ and skeletal remodeling.
In pink salmon specifically, cortisol levels rise over 20-fold in
both males and females (89) being thus likely that GCs may
have important effects over bone metabolism. Despite the fact
that most fish do not appear to undergo important skeletal
changes as they age, the use of fish as models for probing into
aging-related health conditions with impacts on bone mineral
metabolism in human offers ample possibilities, since they can be
treated and selected to simulate such conditions, including those
directly or indirectly related to disturbances in circulating GCs
(90–93).
CONCLUSION
In response to a variety of stressful situations and/or stimuli that
challenge the internal equilibrium in vertebrates, bone appears to
be a target organ for stress-induced GCs produced by HPA/HPI
axis activation. In mammals, as in fish, elevated GC levels
sustained over time result in bone resorption, which alters the
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mineral balance and damages the bone structure. Although this
evidence suggests that stress-induced GCs may act in a similar
fashion to that of therapeutic GCs, there is a gap in the knowledge
about the cellular and molecular mechanisms involving the stress
response, cortisol and bone mineral metabolism in vertebrates.
Studies utilizing mammalian models based on the pathological
increase of endogenous GCs and pharmacological GCs reported
that the bone effect of these hormones could be due to its direct
action on osteoblasts (34, 35). However, the actions of stress-
induced GCs on bone cells as well as the interactions between
GCs and other factors regulating bone homeostasis are currently
unknown.
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